https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
The review examines the current evidence and future approach to optimising outcomes for renal protection in patients with diabetes. © 2020 John Wiley Sons Ltd.Diabetic kidney disease (DKD) is the primary cause of chronic kidney disease around the globe and is one of the main complications in patients with type 1 and 2 diabetes. The standard treatment for DKD is drugs controlling hyperglycemia and high blood pressure. Renin angiotensin aldosterone system blockade and sodium glucose cotransporter 2 (SGLT2) inhibition
Like
Comment
Share
